| Bibliography: |
Publications, peer reviewed:
Kempiak S, Lee P, Pelle MT. Rhinophyma treated with cryosurgery. Dermatol Surg, 2009, in print.
Lesesky E, Pelle MT. Off-Centerfold: Cutaneous manifestations of gout. Arch Dermatol 2007;143:1201-6.
Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol 2004;51:499-512.
Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis and subtype classification. J Am Acad Dermatol 2004;51:327-41.
Reich HL, Crawford GH, Pelle MT, James WD. Group B Streptococcal Toxic Shock-like Syndrome. Arch Dermatol; 2004:140:163-6.
Pelle MT, Callen JP. Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Arch Dermatol 2002;138:1231-33.
Pelle MT, Tyler WB, Pride HB. Clinical Review: Eccrine angiomatous hamartoma. J Am Acad Dermatol 2002;47:429-35.
Pelle MT, Miller OF. Dermatologic manifestations and management of vascular steal syndrome in hemodialysis patients with arteriovenous fistulas. Arch Dermatol 2002;138:1296-98.
Pelle MT, Miller OF. Debridement of necrotic eschar with 40% urea speeds healing of residual limbs and prevents further surgery. Arch Dermatol 2001;137:1288-90.
Mowad CM, Pelle M, Elenitsas R. Laugier-Hunziker Syndrome. In: James WD, Elston D. (Chief Eds.); eMedicine Dermatology. St. Petersburg: eMedicine Corporation, 2000.
Anderson CK, Mowad CM, Goff ME, Pelle MT. Bullous pemphigoid arising in surgical wounds. Brit J Dermatol 2001;145:670-672.
Chapters and Reviews:
Pelle MT. Rosacea. Fitzpatrick’s Dermatology in General Medicine, 2008, 7th Ed. Chap 79. Wolff K, Goldsmith L, Katz S, Gilchrest BA, Paller AS and Leffell D, Editors. McGraw Hill Publishing, pp.703-709.
Pelle MT. Drugs for the Skinternist. Dermatologic Drug Therapy.2007, 2nd Ed. Chap 27. Wolverton, S. Editor, Elsevier, Inc. pp. 501-522.
Pelle MT. Issues and Advances in Cutaneous Lupus Erythematosus. Adv Dermatol 2006;22:55-65. James WD, Cockerell CJ, Maloney ME, Paller AS, Yancey KB, Editors. Mosby Publishing.
Pelle MT. Rosacea Management: An Inside Look at Topical Therapy. Practical Dermatol 2005;2(4):32-36.
Pelle MT. Rosacea Therapy Update. Advances in Dermatology, Vol 19, 2003, pp 139-70.
Pelle MT, Werth VP. Cutaneous Vasculitis. In press, Conn’s Current Therapy, 56th Ed., 2003, W. B. Saunders Co.
Pelle MT, Werth VP. Thalidomide in Cutaneous Lupus Erythematosus. Amer J Clin Dermatol 2003; 4(6):379-87.
|
| Lectures and Presentations: |
Hair Loss, Hair Removal and Hair Restoration in Women, Topics and Advances in Internal Medicine, Lecturer, Annual CME Course, Department of Medicine, UCSD Medical Center. San Diego, CA, March 10, 2009.
Introduction to Patch Testing, Topics and Advances in Internal Medicine, Lecturer, Annual CME Course, Department of Medicine, UCSD Medical Center. San Diego, CA, March 10, 2009.
The New UV: Applications of Narrowband UVB and UVA-1 Phototherapy. Lecturer, Pacific Dermatologic Association 59th Annual Meeting, San Diego, CA, August 24, 2007.
Connective Tissue Disease: Therapeutic Advances. Guest Lecturer, Calgary Society of Dermatology Grand Rounds, Calgary, Alberta, Canada, April 21, 2007.
Dermatology Pearls. Topics and Advances in Internal Medicine, Lecturer, Annual CME Course, Department of Medicine, UCSD Medical Center. San Diego, CA, February 24, 2007.
Challenging Cases. Lecturer, Forum 517, American Academy of Dermatology Summer Meeting, San Diego, CA, July 29, 2006.
Widespread Cutaneous Sarcoidosis. Lecturer, Cutaneous Manifestations of Internal Disease Forum 511, American Academy of Dermatology Summer Meeting, San Diego, CA, July 28, 2006.
Collagen Vascular Disorders in Skin of Color. Lecturer, Skin of Color Course 101, American Academy of Dermatology Summer Meeting, San Diego, CA, July 27, 2006.
Dermatologic Therapy Review, Lasers in Dermatology, Skin Signs of Systemic Disease, Bullous Diseases Symposium and Connective Tissue Disorders (5 lectures). Lecturer, Dubai Dermatology Review Course, April 17-19, 2006, Dubai, United Arab Emirates.
Psoriasis Therapeutics. Presentation to Targegen Inc. Advisory Board, San Diego, CA, March 16, 2006.
Lasers in Dermatology, Topics and Advances in Internal Medicine, Lecturer, Annual CME Course, Department of Medicine, UCSD Medical Center. San Diego, CA, March 5, 2006.
Rosacea Update. Lecturer, Forum, American Academy of Dermatology Annual Meeting, San Francisco, CA, March 3, 2006.
Therapeutic Focus on Connective Tissue Disorders. Lecturer, Focus Session: American Academy of Dermatology Annual Meetings, Washington, DC, February 3, 2007, San Francisco, CA, March 5, 2006 and New Orleans, LA, February 22, 2005.
Cutaneous Lupus. Guest Lecturer, UCSD Dermatology Grand Rounds, January 26, 2006.
Birt Hogg Dube Syndrome. Lecturer, Medical Dermatology Symposium, American Academy of Dermatology, Annual Summer Meeting, New York, NY, July 30, 2004.
Palisaded and Neutrophilic Granulomatous Dermatitis. Abstract presentation. Medical Dermatology Society Meeting. Washington, D.C., February 5, 2004.
Neonatal Lupus Erythematosus. Lecturer, Medical Dermatology Symposium, American Academy of Dermatology, Annual Summer Meeting, Chicago, IL, July 27, 2003.
Medical Dermatology. Guest lecturer: Temple University Medical Center, Department of Internal Medicine, June 9, 2003.
Rosacea Update. Lecturer, Focus Session: American Academy of Dermatology Annual Meeting, San Francisco, CA, March 21, 2003
Retinoids and Rosacea. Presentation to Johnson & Johnson Advisory Board, Philadelphia, PA, May, 2002.
Skin signs of HIV infection. Lecturer, Dermatology Core-Curriculum Course for Medical Students, University of Pennsylvania School of Medicine, Philadelphia, PA, April 23, 2002.
Pediculosis. Lecturer, Dermatology Core-Curriculum Course for Medical Students, University of Pennsylvania School of Medicine, Philadelphia, PA, April 25, 2002 and Boston University School of Medicine, Boston, MA, January 5, 2004.
Teaching for Teachers. Lecturer with Discussion Group: Dermatology Teachers Exchange Group (DTEG), Annual Meeting, Chicago, IL, October 4, 2002.
Family Practice Board Review Course: Dermatology Review. Lecturer, Renaissance Hotel, Philadelphia Airport, June 11, 2003 and July 2, 2002.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 4 minute talk: Gross and Microscopic Symposium. American Academy of Dermatology, New Orleans, LA, February 23, 2002.
Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Abstract presentation: Medical Dermatology Society Annual Meeting, New Orleans, LA, February 21, 2002.
Picking an Assessment Tool. Lecturer: ACGME Resident Competencies. Graduate Medical Education Committee, University of Pennsylvania, Philadelphia, PA, January 18, 2002.
Skin Signs of Systemic Disease. Lecturer, Department of Internal Medicine Noon Conference, Pennsylvania and Presbyterian Hospitals, Philadelphia, PA. November 16, 2001, January 28, 2002, November 15, 2002.
Dermatologic Emergencies. Lecturer, Department of Internal Medicine Noon Conference, Pennsylvania and Presbyterian Hospitals, Philadelphia, PA. September 24, 2001, September 14, 2001 and September 6, 2002.
ACGME Resident Competencies and the 360-Degree Global Evaluation Tool. Lecture with Discussion Group: Dermatology Teachers Exchange Group, Annual Meeting, Chicago, IL, September 7, 2001.
Cosmetic Dermatology: The Aging Face. Lecturer, Grand Rounds, Department of Dermatology, Geisinger Medical Center, Danville, PA, December 14, 2000 and Resident Lecture: University of Pennsylvania, Philadelphia, PA, January 29, 2002.
A twenty-year progression of X-linked recessive epidermodysplasia verruciformis of Lewandowsky and Lutz with review of recent molecular advances. 4 minute talk: Gross and Microscopic Symposium. American Academy of Dermatology, Washington, DC, March, 2001.
Pigmented Purpuric Dermatosis: Lecturer, Dermatology Annual CME Course, Geisinger Medical Center, Danville, PA, May 17, 2000.
Psoralen and UVA Photochemotherapy: Lecturer, Grand Rounds, Department of Dermatology, Milton S. Hershey Medical Center, Hershey, PA, December 2, 1999.
Eccrine angiomatous hamartoma Poster: Society of Pediatric Dermatology, Annual Meeting, Crystal Lake, Michigan, July, 1999.
|
| Clinical Trials: |
“Phase 2 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Chronic Hidradenitis Suppurativa.” Sponsor: Abbott Pharmaceuticals, February, 2009. Principal Investigator.
“Multicenter, Open-label Study to Assess the Efficacy and Safety of Infliximab Therapy in Patients with Plaque Psoriasis who had an Inadequate Response to Etanercept.” PSUNRISE Trial. Sponsor: Centocor, October, 2008. Principal Investigator.
“Multicenter, Open Registry of Patients with Psoriasis who are Candidates for Systemic Therapy including Biologics.” PSOLAR Registry. Sponsor: Centocor, April, 2008. Principal Investigator.
“Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects who Completed a Preceding Psoriais Study with ABT-874. M10-016. Sponsor: Abbott Pharmaceuticals, January, 2008, ongoing. Principal Investigator.
“Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects with Moderate to Severe Chronic Plaque Psoriasis. M06-890. Sponsor: Abbott Pharmaceuticals, January, 2008, ongoing. Principal Investigator.
“Observational Post-Marketing Safety Surveillance Registry of EnbrelTM (etanercept) for the Treatment of Psoriasis.” Observe-5 Registry. Sponsor: Amgen, May, 2007, ongoing. Principal Investigator.
“Acne Free vs. Proactiv for the Treatment of Moderately Severe Acne Vulgaris.” Cosmeceutical. Sponsor: University Medical, Inc., August, 2006, ongoing. Principal Investigator.
“Acne Free vs. Proactiv for the Treatment of Mild to Moderate Acne Vulgaris.” Cosmeceutical. Sponsor: University Medical, Inc., April, 2006. Independently contracted physician for data measurements (acne lesion counts and erythema/dermatitis assessment).
“Pulsed Dye Laser as Adjunctive Therapy for Discoid Lupus Erythematosus.” Investigator initiated trial, 2002. Site: University of Pennsylvania, Department of Dermatology. Pilot study to evaluate efficacy of therapy. Principal Investigator.
“Sub-Antimicrobial-Dose Doxycycline for the Treatment of Papulopustular Rosacea.” Investigator initiated trial, 2002. Site: University of Pennsylvania, Department of Dermatology. Pilot study to evaluate efficacy of therapy. Principal Investigator: Michelle Pelle, M.D.
“Minimal Erythema Dose (MED) testing to Predict Narrowband UVB Dosing in Patients with Light-Responsive Dermatoses”. Investigator initiated review, 2002. Site: University of Pennsylvania, Department of Dermatology. Retrospective review of patients attending University-based Phototherapy Center. Primary Investigator: Abby Van Voorhees, M.D. My role: data collection.
“Apligraf for the Treatment of Venous Leg Ulcers.” Phase IV trial. Sponsor: Novartis Pharmaceuticals, 2000-2001. Site: Geisinger Medical Center Department of Dermatology. Principal Investigator: O. Fred Miller, M.D. My role: data collection.
|
